Cargando…

Long non-coding RNA FOXD2-AS1 regulates the tumorigenesis and progression of breast cancer via the S100 calcium binding protein A1/Hippo signaling pathway

Breast cancer is one of the most prevalent cancer types and is accompanied by a high incidence and mortality rate, severely threatening women's health globally. Long non-coding RNA forkhead box D2 adjacent apposite strand RNA 1 (lncRNA FOXD2-AS1) has been identified to function as an oncogene i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Pei, Xue, Jinhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447301/ https://www.ncbi.nlm.nih.gov/pubmed/32945354 http://dx.doi.org/10.3892/ijmm.2020.4699

Ejemplares similares

Interaction of the Hippo Pathway and Phosphatases in Tumorigenesis
por: Sarmasti Emami, Sahar, et al.
Publicado: (2020)

FOXD1‐AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway
por: Wu, Qiong, et al.
Publicado: (2020)

The role of the Hippo pathway in human disease and tumorigenesis
por: Barron, Daniel A, et al.
Publicado: (2014)

LMNB1 targets FOXD1 to promote progression of prostate cancer
por: Huang, Yuanshe, et al.
Publicado: (2023)

Reduction of GAS5 and FOXD3-AS1 long non-coding RNAs in patients with bipolar disorder
por: Zamani, Bita, et al.
Publicado: (2023)

Downregulation of the long non-coding RNA FOXD2-AS1 inhibits cell proliferation, migration and invasion in osteosarcoma
por: Zhang, Haomeng, et al.
Publicado: (2019)

The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1
por: Su, Feng, et al.
Publicado: (2018)

PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway
por: Fujimoto, Daisuke, et al.
Publicado: (2015)

Long noncoding RNA FOXD2‐AS1 aggravates hepatocellular carcinoma tumorigenesis by regulating the miR‐206/MAP3K1 axis
por: Hu, Wei, et al.
Publicado: (2020)

Long non-coding RNAs MACC1-AS1 and FOXD2-AS1 mediate NSD2-induced cisplatin resistance in esophageal squamous cell carcinoma
por: Xue, Wenhua, et al.
Publicado: (2020)

Activating Hippo Pathway via Rassf1 by Ursolic Acid Suppresses the Tumorigenesis of Gastric Cancer
por: Kim, Seong-Hun, et al.
Publicado: (2019)

SUMOylation of RALY promotes vasculogenic mimicry in glioma cells via the FOXD1/DKK1 pathway
por: Cao, Shuo, et al.
Publicado: (2023)

FOXD3 regulates anaplastic thyroid cancer progression
por: Yin, Huabin, et al.
Publicado: (2017)

Fascin induces melanoma tumorigenesis and stemness through regulating the Hippo pathway
por: Kang, Jiaxin, et al.
Publicado: (2018)

TAp63 suppresses mammary tumorigenesis through regulation of the Hippo pathway
por: Su, X, et al.
Publicado: (2017)

Long non-coding RNA FOXD2-AS1 promotes cell proliferation, metastasis and EMT in glioma by sponging miR-506-5p
por: Zhao, Juan, et al.
Publicado: (2020)

m(6)A methyltransferase METTL3-mediated lncRNA FOXD2-AS1 promotes the tumorigenesis of cervical cancer
por: Ji, Fei, et al.
Publicado: (2021)

Hsa_circ_0005273 facilitates breast cancer tumorigenesis by regulating YAP1-hippo signaling pathway
por: Wang, Xuehui, et al.
Publicado: (2021)

Circulating Serum Exosomal Long Non-Coding RNAs FOXD2-AS1, NRIR, and XLOC_009459 as Diagnostic Biomarkers for Colorectal Cancer
por: Yu, Miao, et al.
Publicado: (2021)

LncRNA FOXD3-AS1 Promotes Tumorigenesis of Glioma via Targeting miR-128-3p/SZRD1 Axis
por: Li, Zhang, et al.
Publicado: (2021)

Pro-inflammatory activity of long noncoding RNA FOXD2-AS1 in Achilles tendinopathy
por: Ke, Xiaoting, et al.
Publicado: (2023)

lncRNA FOXD2-AS1 promotes hemangioma progression through the miR-324-3p/PDRG1 pathway
por: Zhao, Tiancheng, et al.
Publicado: (2020)

S100 Calcium Binding Protein A16 Promotes Cell Proliferation by triggering LATS1 ubiquitin degradation mediated by CUL4A ligase to inhibit Hippo pathway in Glioma development
por: Hu, Yifang, et al.
Publicado: (2023)

RP1-59D14.5 triggers autophagy and represses tumorigenesis and progression of prostate cancer via activation of the Hippo signaling pathway
por: Zhong, Bing, et al.
Publicado: (2022)

Calcium, an Emerging Intracellular Messenger for the Hippo Pathway Regulation
por: Wei, Yiju, et al.
Publicado: (2021)

Loss of the emei tumor suppressor promotes tumorigenesis via the JNK and Hippo pathway
por: Yang, Shuai, et al.
Publicado: (2022)

Correction to: Hsa_circ_0005273 facilitates breast cancer tumorigenesis by regulating YAP1-hippo signaling pathway
por: Wang, Xuehui, et al.
Publicado: (2021)

LncRNA FOXD3-AS1 Promotes Tumorigenesis of Glioma via Targeting miR-128-3p/SZRD1 Axis [Retraction]
Publicado: (2022)

Long non‐coding RNA SOX21‐AS1 enhances the stemness of breast cancer cells via the Hippo pathway
por: Li, Lanzhen, et al.
Publicado: (2020)

Interaction of S100A1 with LATS1 promotes cell growth through regulation of the Hippo pathway in hepatocellular carcinoma
por: Guo, Qingping, et al.
Publicado: (2018)

Up-regulation of FOXD1 by YAP alleviates senescence and osteoarthritis
por: Fu, Lina, et al.
Publicado: (2019)

FOXD1 expression-based prognostic model for uveal melanoma
por: Luo, Yang, et al.
Publicado: (2023)

The long noncoding RNA HOTAIR activates the Hippo pathway by directly binding to SAV1 in renal cell carcinoma
por: Hu, Guanghui, et al.
Publicado: (2017)

Targets for Renal Carcinoma Growth Control Identified by Screening FOXD1 Cell Proliferation Pathways
por: Bond, Kyle H., et al.
Publicado: (2022)

Hippo Signaling Pathway as a Central Mediator of Receptors Tyrosine Kinases (RTKs) in Tumorigenesis
por: Azad, Taha, et al.
Publicado: (2020)

Long non‐coding RNA FOXD2‐AS1 contributes to colorectal cancer proliferation through its interaction with microRNA‐185‐5p
por: Zhu, Yanyan, et al.
Publicado: (2018)

FOXD3-AS1/miR-128-3p/LIMK1 axis regulates cervical cancer progression
por: Yang, Xiufang, et al.
Publicado: (2021)

KCTD11 inhibits progression of lung cancer by binding to β‐catenin to regulate the activity of the Wnt and Hippo pathways
por: Yang, Man, et al.
Publicado: (2021)

Association of FOXD1 variants with adverse pregnancy outcomes in mice and humans
por: Laissue, Paul, et al.
Publicado: (2016)

Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas
por: Escoll, Maribel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_khurddc6jd8kkhgrgodhlcuhmm